Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Losartan to Decrease the Risk of Postoperative Arthrofibrosis Following Primary and Revision Anterior Cruciate Ligament Reconstruction

NCT07135687 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT07135687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07135687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Losartan to Decrease the Risk of Postoperative Arthrofibrosis Following Primary and Revision Anterior Cruciate Ligament Reconstruction
Lead sponsor
Rush University Medical Center
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
December 31, 2028
Enrollment
144 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acl injury, acl reconstruction, scar formation